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Thepurpose ofthis studywas to examine the mechanisms oflead (Pb) uptake byhuman intesti-
nal cells and to compare the intestinal transport and relative lead-chelating ability of two
diastereoisomeric forms (i.e., nso and racemic) of2,3-dimercaptesuccinic acid (DMSA). The
model used wasthe human aden oma (Caco-2) cell monolayr.TheCaco-2 cells were cul-
tuned inflask foreamination ofcellular uptake ofleadands uent cheion ofthelead by
the DMSA isomers. For asessment ofthe compara in l port ofthe dianeoso-
mers, the Caco-2 cells were cultured on semipermeable supports. The effects of N-ethyl-
maleimide and 1,25-dhydroxyvitamin D3 (vitamin 13) on the uptake oflead by the Caco-2
monolayer were mined to determine the contdbutions ofsufiydryl-binding and calcium-
binding protein, e , to thelead uptake process. Analyis oflead was performed using
bothmacro- admicro-proton-indued X-rayemission (P13E), andDMSAwasmsured spec-
trophotometricallyfollowingderivtizaion with 5,5'-dithiobis-2-nitrobenzoic acid. Resultsfrom
micro-PIXE imaging suggest that lead is bound on the surface ofthe cell, and that ydryl
biding may be an important step in theuptake ofleadbytheCaco-2cells. Macro-PIXE results
indicate hat thercemicformofDMSAmaybe moreeffectiv in chela leadfromwithin the
cell. Comparison ofthe transport ofthe two DMSA dhsetreoisomers indicates that the racemic
form is tnported acss the Caco-2 monolayer more.readily than the musoform. KIey worth
Caco-2, 2,3-dimercaptosuccinic acid, lead, proton-induced X-ray emission. Environ Heakh
Perspt107:111-115 (1999). [Online 11 January 1999]
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Lead intoxication is a serious health prob-
lem. Blood levels of lead as low as 10-15
pg/dl, and possibly lower, are linked to
undesirable developmental effects in human
fetuses and children (1). These effects
include impaired neurobehavioral develop-
ment and other possible effects on early
development andgrowth.
Currently the only orally administered
treatment for lead poisoning is meso-2,3-
dimercaptosuccinic acid (meso-DMSA),
which is available commercially as Succimer
(Chemet, Bock Pharmacal Co., St. Louis,
MO). This compound was approved by the
Food and Drug Administration in 1991 for
treatment of childhood lead intoxication
when blood lead levels exceed45 g/dl. Since
that time, there has been an increasing use of
meso-DMSA for the treatment of children
withbloodleadlevels aslowas 20pg/dl ().
Despite its increasing clinical use, meso-
DMSA has several disadvantages. It is virtu-
ally insoluble in acidic solution and only
slightly soluble in water. These properties
may reduce the gastrointestinal absorption
ofthedrug and result in the need for a com-
paratively higher dose of meso-DMSA to
maintain an effective blood level for chela-
tion therapy. Infact, studies have found that
only 20.6% of the administered dose of
meso-DMSA is found in the urine as total
meso-DMSA 14 hr after the drug is given
orally (3,4). In addition, two unpublished
bioavailability studies conducted at McNeil
Laboratories indicate that the oral bioavail-
ability ofthe commercial meso-DMSA for-
mulawas only about 25% (5). Another dis-
advantage of meso-DMSA is that it report-
edly removes lead only from the extracellu-
lar fluid ofplasma (6), and thus it may be
unable to mobilize lead from within the
brain, bone marrow, or other soft tissues
where lead can deposit.
DMSA exists in two diastereoisomeric
forms, meso and racemic (dl-). The dl-
DMSA form is soluble in water, strongly
acidic solutions, and in nonaqueous sol-
vents such as ethyl ether (7). On this basis
it was proposed that dl-DMSA will be
absorbed across the intestinal epithelium
more efficiently than the meso diastereoiso-
mer upon oral administration and that it
may be a more effective chelator for the
treatment oflead poisoning (8).
The efficacy of dI-DMSA in the treat-
ment oflead poisoning has not been studied
in either human subjects or animals.
However, in vivo studies with dl-DMSA
showed that it was more effective than mesa-
DMSA in reducing mortality and increasing
the excretion ofmercury and cadmium from
the body in cases ofacute poisoning (9-11).
The results ofthese in vivostudies with mer-
cury and cadmium have been rationalized
recently on the basis ofhigher formation
constants for the complexes of dl-DMSA
with cadmium and mercury at physiological
pH (1X.
To help determine whether dl-DMSA
might be more effective than meso-DMSA
in the treatment oflead poisoning, we used
the Caco-2 monolayer cell culture model to
elucidate the comparative epithelial transfer
ofthe two forms ofDMSA. The suitability
of this model for elucidating the transport
pathways of a wide variety of molecules,
including peptides, proteins, and metals
(e.g., calcium and cadmium), is well estab-
lished (13,14). The advantages of this
model include 1) rapid assessment of
absorption and metabolism ofmolecules, 2)
independent access to both the apical (AP)
and basolateral (BL) sides ofthe cell mono-
layer to permit monitoring both the appear-
ance and disappearance of solutes, 3) the
use of human cells as opposed to tissues
from animal sources, 4) greater cell viability
compared with isolated or perfused systems,
and 5) better reproducibility (15). Recent
studies (15-17) have shown good correla-
tion between data from this model and
other well-established in vitro and in situ
models traditionally used for conducting
such absorption studies (16,18).
The uptake and internalization oflead
has been shown to mimic that ofcalcium in
chick and bovine intestinal cells (19).
Calcium uptake involves an initial internal-
ization step followed by intracellular binding
to calcium-binding protein (CaBP) (20),
which is thought to act as a "ferry" for trans-
porting calcium across the intracellular space.
Transcription of CaBP is enhanced by the
presence ofvitamin D3 in the nucleus. When
blood calcium levels fall, the kidney is stimu-
lated by parathyroid hormone to synthesize
more vitamin D3 from existing vitamin D
(19). Increased levels ofvitamin D3 cause the
gastrointestinal cells to produce more CaBP,
Address correspondence toJ. Blanchard, Department
of Pharmacology and Toxicology, University of
Arizona, College of Pharmacy, 1703 East Mabel
Street, Tucson,AZ 85721 USA
We acknowledge the skilled assistance of Don
Ashbaugh and Lawrence MacIntyre for their help
with the PIXE analysis.
This work was made possible by a grant from the
Flinn Foundation. Support by grant no.
P30ES06694 (NIEHS) from the Southwest
Environmental Health Sciences Center, The
University ofArizona, is gratefullyacknowledged.
Received 16 December 1997; accepted 17
September 1998.
Environmental Health Perspectives * Volume 107, Number 2, February 1999 1 1lArticles * Pigman et al.
ultimately resulting in increased uptake of
calcium from thegastrointestinal tract (19).
A micro-proton-induced X-ray emis-
sion (micro-PIXE) technique (21) was used
to assess the uptake oflead by the Caco-2
cells. This was accomplished by measuring
the concentrations oflead, zinc, and other
essential elements in cells exposed to lead
solutions. The relative ability of the two
forms ofDMSA to mobilize lead, zinc, and
other essential elements from inside the
cells was assessed using macro-PIXE (22).
This technique provides information on the
concentrations ofelements above atomic
number 11 and is the only analytical method
that can measure 20-30 elements nondestruc-
tively in a single small sample (<5 mg) with a
detectionlimitof1-5 ppm (dryweight).
The goal of the present study was to
examine the behavior ofthe two isomers of
DMSA in a tissue culture model by using
PIXE to quantitate lead within cells treated
with both lead and dl- or meso-DMSA. In
addition to quantitative assessment oflead
in the Caco-2 cells, micro-PIXE was used
to qualitatively assess the location of lead
within the cells.
Materials and Methods
Cell culture. Caco-2 cells (American Type
Culture Collection, Rockville, MD) were
cultured in T-75 flasks as described previ-
ously (15). The protocol forseeding the cells
in Transwell cell culture inserts (Costar,
Cambridge, MA) was as described earlier
Table 1. Summary of results from the lead uptake
optimization experiments
Exposure Pb uptake Lactate
time ± SE dehydrogenase
(hr) Pb (,uM) (ng/cm2) (% total ± SE)
0.5 500 1.1 x105+1.2x104 0.21 ±0.21
2 80 22.3±6.9 10.6±3.6
4 50 553.2±122.2 58.6±2.9
SE, standard error.
(15), with the following modifications. The
12-well tissue culture dusters were prepared
in the laminar flow hood by pipetting 1.5
ml of complete medium (38°C) into each
well. A Transwell insert was placed in each
well using a pair ofsterile forceps. Aliquots
of a 7 x 104 cell suspension (0.5 ml) were
then pipetted into the apical chamber of
each Transwell insert, and the plates were
transferred to the incubator.
Cell viability studies. Before the lead
uptake and DMSA transport experiments,
we conducted cytotoxicity assays to ensure
that the viability of the cells was not com-
promised in the presence ofthe experimen-
tal compounds at the concentrations to be
tested. This was accomplished bycomparing
the amount oflactate dehydrogenase (LDH;
assay kit DG1340K, Sigma, St. Louis, MO)
released by the cells after treatment with a
range of concentrations of lead or the
DMSAdiastereoisomers with the amount of
LDH released by a control exposed to
serum-free medium. LDH, an enzyme
released from within a cell when it dies, is a
good indicator of the damage to a popula-
tion of cells caused by experimental treat-
ment. The toxicities ofvitamin D3 and N-
ethylmaleimide (NEM) were determined in
previous studies involving Caco-2 cells (23),
and the experimental concentrations from
these previous experiments were adopted.for
thepresent study.
The cytotoxicity studies were per-
formed in 96-well tissue culture plates
(Falcon/Becton Dickinson Labware,
Lincoln Park, NJ). For the transport stud-
ies, eight-well strip tissue culture inserts
(Nalge-Nunc International, Naperville, IL;
miniature Transwells) were used to mimic
the conditions of the actual experiment.
The cells were seeded (4 x 104 cells/ml)
into the 96-well culture plates with a mul-
tichannel pipet. In the case ofthe cytotoxi-
city studies for the uptake experiments, the
cell suspension was seeded in 200-pl
aliquots directly into the wells of the 96-
well plate. For the DMSA transport cyto-
toxicity studies, 100 pl ofcomplete medi-
um (38°C) was added to each well. The 8-
well strip inserts were then placed into the
plate, and 50-pl aliquots ofcell suspension
were pipetted into each apical chamber.
The cells were then placed in the incubator
overnight to allow them to attach to their
respective substrates.
On the day after seeding, the medium
was removed from the wells using a multi-
channel pipet. The medium was then
replaced with serum-free medium that con-
tained various concentrations ofthe experi-
mental compound to be tested. This solu-
tion was allowed to remain in contact with
the cells for 30 min, after which it was
removed using a 200-pl pipet and placed in
plastic microcentrifuge tubes for storage at
4°C until the time of assay. All samples
wereassayed forLDH within 24 hr.
The assay for LDH release was per-
formed according to the instructions
included with the Sigma LDH measure-
ment kit with the following modifications.
The kinetic assaytechnique was abandoned
in favor of a less complicated and equally
informative end point assay. To initiate the
analysis, 100 p1l ofsample from the 96-well
assaywas added to a cuvette containing 2.5
ml ofthe reagents from the LDH measure-
ment kit. This mixture was allowed to
equilibrate at room temperature for 20 min
and then assayed spectrophotometrically at
340 nm (Beckman Instruments, Fullerton,
CA) as detailed in the instructions.
Optimization oflead concentrations
and exposure times. Before performing the
lead uptake experiments, we assessed the
optimum conditions for lead uptake by
incubating each flask ofcells with 10 ml of
serum-free medium (SFM) containing dif-
ferent concentrations of lead (PbNO3,
99.9% pure; J.T. Baker, Phillipsburg, NJ)
for various exposure times (see Table 1).
Figure 1. (A) Light microscopy
image of the area scanned by
the PIXE beam. (B) Micro-PIXE
image of the Caco-2 cell
showing high lead concentra-
tions in the cell membrane. (C)
Scale representing the counts
per color inthe images.
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The medium from each flask was then
assayed for LDH as described previously.
The optimum lead concentration was con-
sidered to be the one that resulted in the
highest intracellular lead concentration and
did not induce cell death as indicated by
the LDH assay.
Micro-PIXE measurement oflead
uptake by the Caco-2 cells. For the micro-
PIXE experiments, the Caco-2 cells were
seeded onto 1-cm diameter microscope
cover slips that had been placed in 12-well
tissue culture plates, at a seeding density of
approximately 3 x 106 cells/ml. The cells
were cultured for 1-2 days to allow them
to attach to the cover slips. The cells in the
vitamin D3 experimental group were treat-
ed with 100 nM vitamin D3 24 hr before
exposure to lead. The NEM treatment
group was exposed to 500 pM NEM for 20
min immediately before thelead exposure.
To initiate the uptake experiments, the
medium was aspirated from the wells and
replaced with 2 ml ofSFM containing 500
pM lead. After 30 min of exposure to the
lead, the SFM was removed and the cell
layers gently rinsed once with SFM.
Following the rinsing step, the treatments
were added to the wells. A treatment group
consisted ofthreewells. The four treatment
groups were 1) 500 pM lead only, 2) cells
pretreated with 100 nM vitamin D3, then
500 pM lead, 3) cells pretreated with 500
pM NEM, then 500 pM lead, and 4) cells
pretreated with both vitamin D (100 nM)
and NEM (500 pM), followed by exposure
to 500 pM lead.
After 30 min of exposure to the 500
pM lead, the cells were gently rinsed with
SFM. Forceps were used to remove the
cover slips from the wells. The cover slips,
with their attached cell layer, were then
coated by dipping them into a water bath
on the surface ofwhich had been floated a
thin layer ofcarbon. The carbon layer was
necessary to disperse charge throughout the
samples and thereby reduce background.
The coated samples were placed in a vacu-
um chamber attached to the micro-PIXE
apparatus and allowed to dry overnight.
Cells were examined visually using light
microscopy to position them directly in the
path of the micro-PIXE beam. The cells
were then subjected to analysis by micro-
PIXE and the resulting images stored on
computer diskforfuture examination.
Chelation ofleadfrom the Caco-2 cells
by the DMSA diareoisomers. We assessed
the comparative chelating ability ofthe two
DMSA diastereoisomers by first exposing a
flaskofcells to 500pM lead for 30 min. The
lead-containing medium was then aspirated
and the cells were rinsed once with SFM.
After rinsing, 10 ml ofSFM alone, or SFM
containing 50 pM meso-DMSA or 50 pM
dl-DMSA was added to each flask. After 15
min ofexposure to the DMSA diastereoiso-
mers, the cell monolayers from each experi-
mentwerewashed oncewith SFM alone and
then with a 1 x trypsin-EDTA solution to
chelate any remaining extracellular lead and
to remove the cells from the substrate. After
8-10 min of trypsinization, the cells were
scraped from the substrate with a cell lifter
and centrifuged (Model TJ-6, Beckman
Instruments) for 10 min at 400g. The super-
natant was then aspirated. The resulting cell
pellet was transferred by pipet to a round
piece offilter paper (6 mm in diameter) that
had been placed on a piece of mylar (2.5
pm) stretchedover anX-rayfluorescence cup
(3.2 cm in diameter; Chemplex Industries,
Tuckahoe, NY). The pellet was allowed to
dry overnight and was then covered with
another sheet ofmylar. This preparation was
then analyzed using macro-PIXE. To nor-
malize the data forpossible differences in cell
density, we measured the lead-to-iron ratio
foreach treatment group.
Transport ofthe DMSA diastereoiso-
mers across the Caco-2 monolayer. Caco-2
cells were routinely seeded into Transwell
12-well plate inserts as described previously
(15). To initiate the experiments, the AP
fluid was replaced with transport buffer
alone (Hanks' Balanced Salt Solution with
5.6 mM glucose and 20 mM HEPES, pH
7.2, 38°C), or transport buffer containing
50 pM meso- or dl-DMSA. The basolateral
medium was replaced with transport
buffer. After 15 min of exposure to the
DMSA diastereoisomers, medium from the
basolateral chamber was sampled. The
samples were directly transferred to test
tubes and assayed spectrophotometrically
for DMSA content using Ellman's reagent
(24) to quantitate the amount of DMSA
transported across the monolayer.
Results and Discussion
Cellviability studies. The maximum DMSA
concentration tolerated by the Caco-2 cell
monolayer, without significant cell death
(determined by LDH release), when com-
paredwith the control, was 50 pM for meso-
DMSA and between 25 and 50 pM for db
DMSA (data not shown). This is consistent
Figure 2 (A) Micro-PIXE image oflead concentration in Caco-2 cells pretreated with vitamin D3. (B) Lead concentration in untreated Caco-2 cells. Each color rep-
resents 2 counts onthe scale depicted in Figure 1C.
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Figure 3. (A) Micro-
PIXE image of lead
concentration in Caco-
2 cells pretreated with
N-ethylmaleimide. (B)
Lead concentration in
Caco-2 cells pretreated
with vitamin D, and N-
ethylmaleimide. (C)
Lead concentration in
untreated Caco-2 cells.
with the findings ofAposhian and Aposhian
(6), who found dl-DMSA to have a lower
LD50 than meso-DMSA in mice.
Optimization oflead concentrations
and exposure times. The optimum lead
concentration and exposure time was 500
pM for 30 min. These conditions resulted
in the least amount of cell death and the
highest cellular lead concentrations (see
Table 1). The magnitude of the cellular
lead concentration was an important con-
sideration for the study, due to the fact that
it was difficult to quantitatively assay low
lead concentrations with macro-PIXE.
Quantitating lead in small samples (<5 mg)
proved to be problematic. Initial attempts
to measure lead in cells collected from a
12-well tissue culture plate were unsuccess-
ful, and we decided to use an entire flask of
cells for each trial in order to concentrate
the amount of lead that would be in the
path ofthe macro-PIXE beam.
Micro-PIXE visualization ofthe uptake
ofleadby the Caco-2 cells. After 30 min of
exposure to 500 pM lead, the cell mem-
brane contained a much higher concentra-
tion oflead than the cell interior or the sur-
rounding fluid, as can be seen in the light
microscopy and micro-PIXE image (Fig. IA
and B, respectively). Lead levels in the cells
that were pretreated with vitamin D3
appear, by visual inspection, to be higher
than those ofthe control (lead only) group
(Fig. 2Aand B). These datasuggest thatvit-
amin D3 enhanced the uptake of lead by
the Caco-2 cells, although the lead concen-
tration cannot be quantitated accurately.
Both the NEM and the vitamin D3/NEM
trlcatmIenlit ro0Ups show less lead' in the cells
thali the control groiip (gig. :3A-(:). These
results sulgest that p)1retrelatmlellnt wit] 50()
plM NI1 reduticed the up)take ot lead h
tl( (Cacxo-2 cells, impklinig that thete1' V
h)e al SulIflt[dril-nl]tiecldated step in the ioecihla-
nSn1 Of A Leaduptae 'in this cell line. This
Sotsts tha(It h 1tiniiti* to the cell tnemhrane
nl !V plav .a sig,niJf1icant role i the celltular
Qunantitation of lead chbelattioni by the
dl- aznid nieso-DM,SA diaster-eoisoiniers.
,\l;cn)-o-INIt ilttalnititaltion o0f lcl. n ntnllgia
insie the ('ato-- e11 alter- cxPoStIVe to
othi ilit(o- and (/-l)NSA shosed: that dll-
I)N.SA\ temzoSd .signlificant'.ll (P<().l)
m1ore lead tt-ouz the cells in COMPIai.Son tO
the contol th.an dlidt J.-I)MSA (I;i1. ).
The a1mu10LI11t t) Clead renmosed by the incso
foiri sas not st(ntcaantliodifferent from11
the control, in M 'lWicl n I)N L SA wais utsedl.
These rcesllts indiidcte thiat m/-1)N rA mote
readlil' inhibits the uptake of leadl lw the
Caco-2 cells.
Transport ofdl- and meso-DMSA
across the Caco-2 monolayer. Fang et al.
(12) hypothesized, based upon its higher
solubility in gastric fluids and its more
lipophiic nature, that the dl-DMSA would
more readily penetrate the cell membrane
and therefore the intestinal epithelium. In
fact, significantly larger amounts of 50 pM
dl-DMSA were transported across the
monolayer in comparison to the meso-
DMSA (Fig. 5). The amount of meso-
DMSA transported across the monolayer
was not significantly different from back-
ground. These findings are consistent with
the predictions pertaining to the relative
lipophilicity of dl-DMSA compared with
that of meso-DMSA made by Fang and
Fernando (8).
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Figure 4. Lead-to-iron ratios in Caco-2 cells after
a 15-min exposure to dl- and meso-dimercapto-
succinic acid (DMSA). Error bars indicate stan-
dard error.
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Figure 5. Comparative transport of dl- and meso-
dimercaptosuccinic acid (DMSA) across the
Caco-2 monolayer. Error bars indicate standard
deviation.
Conclusions
The PIXE technique is an effective method
for measuring lead, and possibly other met-
als, in a cell culture system. To achieve max-
imal intracellular lead concentrations that
can be readily quantitated using the macro-
PIXE technique without compromising the
viability ofthe cells, we recommend that the
cells be exposed to high concentrations of
lead for relatively short periods of time.
After 30 min ofexposure ofthe Caco-2 cells
to 500 pM lead, it appeared that the majori-
ty of the lead was localized at the cell sur-
face, indicating that there was an initial
binding to the cell surface. The fact that pre-
treatment ofthe cells with NEM, a known
sulffiydryl group blocker, negated this effect
suggests that binding to sulfhydryl groups is
involved in this process. The observation
that the cells pretreatedwith vitamin D3 fol-
lowed by NEM also showed little lead
uptake suggests that the initial surface bind-
ing of the lead is an important step in the
subsequent internalization of the lead. The
transport ofdl-DMSA across the cell mono-
layer was significantly greater than that of
the meso isomer. Based upon its superior
ability to remove lead from within the
Caco-2 cells exposed to it, the racemic form
of DMSA appears to have the potential to
be a more effective chelator oflead than the
currently used meso form. Further studies to
validate the utility ofthe racemic isomer of
DMSA arewarranted.
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